ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $138,000 | +15.0% | 39,041 | +3.1% | 0.01% | +33.3% |
| Q2 2021 | $120,000 | -9.1% | 37,878 | -1.1% | 0.01% | -25.0% |
| Q1 2021 | $132,000 | +34.7% | 38,306 | -2.0% | 0.01% | +14.3% |
| Q4 2020 | $98,000 | -22.8% | 39,086 | -34.9% | 0.01% | +75.0% |
| Q3 2020 | $127,000 | -42.0% | 60,047 | -38.6% | 0.00% | -33.3% |
| Q2 2020 | $219,000 | +73.8% | 97,742 | +95.7% | 0.01% | +100.0% |
| Q1 2020 | $126,000 | +5.9% | 49,952 | +9.9% | 0.00% | +50.0% |
| Q4 2019 | $119,000 | -33.5% | 45,432 | -8.4% | 0.00% | 0.0% |
| Q3 2019 | $179,000 | – | 49,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |